The West Virginia case is seen as a win for drugmakers following a U.S. Supreme Court setback earlier in the month, but the ...

"Public broadcasting is more than television and radio—it is a lifeline, a classroom, and a platform for candid dialogue and ...

The drugmaker is following in the footsteps of Johnson & Johnson and Eli Lilly in filing suit to force through controversial ...

Johnson & Johnson and other pharma companies aim to change how the 340B Drug Pricing Program functions. Courts must rule if ...

The lawsuits center on the federal 340B drug discount program, which requires drugmakers that receive federal Medicare and ...

The Michigan Senate’s recent passage of Senate Bill 1179, aimed at regulating the federal 340B program, could be ...

HRSA warns Sanofi that its credit model for 340B drugs violates the statute, demanding immediate cessation to avoid penalties ...

Drugmakers may shift their focus to a rebate program for 340B drug discounts as a result of a Supreme Court decision.

The U.S. Supreme Court refused to hear an appeal by a pharmaceutical industry group challenging Arkansas' 340B drug pricing ...

The Health Resources and Services Administration last week directed Sanofi to cease implementation of its 340B rebate ...

Colorado Hospital Association fights for federal 340B funding, a program that benefits nearly 70 hospitals statewide. Learn ...

Four drug manufacturers have announced plans to offer discounted drug prices to safety net providers under the federal 340B program via ...